HeyJaredMaddie Hengerer
- Indexed articles, last 90 days
- 10
- Latest publication
- Aug 13, 2026
- Outlet visibility, for Oncology Nurse Advisor
- Top 5M sites
- Earliest in this view
- Jul 8, 2026
Latest articles
HPV Self-Collection Testing Is Feasible in an Opioid Treatment Program Setting - Oncology Nurse Advisor (opens the original)
Read excerpt
Human papillomavirus (HPV) self-collection testing can expand cervical cancer screening access among patients in the setting of an opioid treatment program, according to research published in JAMA Network Open. Perceived stigma has often led individuals with opioid use disorder to avoid health care interactions, which also leads to low uptake of preventive care, study researchers explained. In this retrospective cohort study, the researchers sought to assess whether offering HPV self-collection
HPV Self-Collection Testing Is Feasible in an Opioid Treatment Program Setting (opens the original)
Read excerpt
Human papillomavirus (HPV) self-collection testing can expand cervical cancer screening access among patients in the setting of an opioid treatment program, according to research published in JAMA Network Open. Perceived stigma has often led individuals with opioid use disorder to avoid health care interactions, which also leads to low uptake of preventive care, study researchers explained. In this retrospective cohort study, the researchers sought to assess whether offering HPV self-collection
Tadalafil May Increase Glaucoma Risk (opens the original)
Read excerpt
Continuous, long-term use of tadalafil, a phosphodiesterase type 5 inhibitor (PDE5i), can increase the risk of developing glaucoma in treated men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to study results published in the British Journal of Ophthalmology. To assess the association between tadalafil and glaucoma, Chien-Chih Chou, MD, MS, of National Taiwan University Hospital, Taipei, Taiwan, and colleagues conducted a multinational, re
Surgical Re-Excision not Associated with Reduced Local Recurrence Risk in DCIS - Oncology Nurse Advisor (opens the original)
Read excerpt
Re-excision was not associated with reduced risk for local recurrence in patients who received breast-conserving surgery for ductal carcinoma in situ (DCIS), according to findings published in Clinical Breast Cancer. “[R]e-excision was not associated with improved local control in patients with DCIS only disease. Local recurrence risk appeared to be driven primarily by patient- and treatment-related factors rather than by surgical re-intervention,” study researchers wrote. “The absence of lower
Surgical Re-Excision Not Associated With Reduced Local Recurrence Risk in DCIS (opens the original)
Read excerpt
Re-excision was not associated with reduced risk for local recurrence in patients who received breast-conserving surgery for ductal carcinoma in situ (DCIS), according to findings published in Clinical Breast Cancer. “[R]e-excision was not associated with improved local control in patients with DCIS only disease. Local recurrence risk appeared to be driven primarily by patient- and treatment-related factors rather than by surgical re-intervention,” study researchers wrote. “The absence of lower
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Oncology Nurse Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.